Le Lézard
Classified in: Health
Subjects: NPT, LEG, WOM, POL, FVT

The 2023 "Moms' Agenda" Is Released


Mom Congress announces the bi-partisan legislation it is calling on Congress to pass; delegates will travel to DC next month to push Congress to prioritize support for mothers.

WASHINGTON, Aug. 24, 2023 /PRNewswire/ -- Today Mom Congress announced the bills included in its 2023 Moms' Agenda - a series of bills to address the urgent challenges mothers face because of woefully inadequate infrastructure to support pregnancy, birth, and early parenting in the U.S. These priorities are even more important than ever post the overturn of Roe v. Wade which reduced a woman's choice about whether to have a baby. 

"If the government is 'pro-life,' then it must be pro-mother. Supporting mothers and families with health and mental healthcare, paid family leave, child care, and child tax credits is pro-life," said Joy Burkhard, Founder of Mom Congress. 

The bills in the Moms' Agenda are purposefully bi-partisan.

"It's time for Congress to come together, not to deepen the political divide. America's moms and families deserve bipartisanship," said Dr. Ebony Wrenn, Director of Mom Congress.

In addition to advocating for paid parental leave and immediately addressing the childcare funding crisis resulting from the American Rescue Plan funding ending on September 30, 2023, the Moms' Agenda includes the following pieces of legislation:

Maternal Health Care Access, Maternal Mortality Prevention 
Midwives for MOMS Act
Healthy Moms and Babies Act
Preventing Maternal Deaths Reauthorization Act
Mothers and Newborns Success Act

Stillbirth Prevention
SHINE for Autumn Act
Maternal Child Health Stillbirth Prevention Act

Maternal Mental Health 
Moms Matter Act

Child Care
Improving Child Care for Working Families Act of 2023
Expanding Child Care in Rural America Act of 2023
Learn more about the Moms' Agenda:
https://www.mom-congress.com/2023-moms-agenda

The Mom Congress fly-in kicks off with the 5th annual Mom Congress "Saving and Supporting Moms" Congressional Briefing on Tuesday, September 19, 2023. View the event details here.

About Mom Congress
Mom Congresstm is a mothers' membership organization that is addressing the most pressing policy issues of motherhood, including what we call the "motherload"? the stress that U.S. mothers carry at higher rates than other developed countries. Each year, passionate mothers convene to connect with influential change agents, be inspired, and learn how to drive change in legislative policy on Capitol Hill. Mom Congress is currently a project of the Policy Center for Maternal Mental Health, a leading maternal mental health organization, and will soon become an independent non-profit organization. Learn more at https://www.mom-congress.com/.

Media Contact:
Crystal McAuley
214-587-4085
[email protected]

SOURCE Mom Congress


These press releases may also interest you

at 22:00
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2  The...

at 21:00
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...

at 20:05
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...

at 20:00
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...

at 19:30
NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the...

at 19:25
Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company's breakthrough RESILIA tissue technology, designed to extend the valve's durability.*...



News published on and distributed by: